AI assistant
Sending…
Aura Biosciences, Inc. — Director's Dealing 2021
Oct 28, 2021
33080_dirs_2021-10-28_d4b3ee86-1482-45c8-a2d7-036d869ee8bb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Aura Biosciences, Inc. (AURA)
CIK: 0001501796
Period of Report: 2021-10-28
Reporting Person: Srivastava Sapna (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $5.48 | 2031-05-14 | Common Stock (53649) | Direct |
Footnotes
F1: The shares underlying this option vest in 48 monthly installments, equal to 2.0833% of the shares, over the 48 months following May 4, 2021.